Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 0.00
March 31, 2026 0.00
December 31, 2025 0.00
September 30, 2025 0.00
June 30, 2025 0.00
March 31, 2025 0.00
December 31, 2024 0.0012M
September 30, 2024 -0.0697M
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 0.00
September 30, 2023 0.00
June 30, 2023 0.00
March 31, 2023 0.00
December 31, 2022 -0.0002M
September 30, 2022 0.0079M
June 30, 2022 0.00
March 31, 2022 0.00
December 31, 2021 -0.1933M
September 30, 2021 -3.974M
June 30, 2021 4.866M
March 31, 2021 217.27M
December 31, 2020 14.03M
September 30, 2020 29.97M
June 30, 2020 32.81M
Date Value
March 31, 2020 2.152M
December 31, 2019 -0.1166M
September 30, 2019 0.1592M
June 30, 2019 11.92M
March 31, 2019 3.007M
December 31, 2018 4.650M
September 30, 2018 0.056M
June 30, 2018 3.955M
March 31, 2018 1.408M
December 31, 2017
September 30, 2017 3.683M
June 30, 2017 2.972M
March 31, 2017 0.2516M
December 31, 2016 0.7579M
September 30, 2016 3.967M
June 30, 2016 0.0323M
March 31, 2016 -0.0047M
February 29, 2016
November 30, 2015
August 31, 2015
May 31, 2015
February 28, 2015 0.00
November 30, 2014 0.00
August 31, 2014 0.00
May 31, 2014 0.00

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Biomerica, Inc. 0.871M
Univec, Inc. 0.0157M
Lantheus Holdings, Inc. 4.505M
IDEXX Laboratories, Inc. -325.19M
Neogen Corp. -0.30M